{
    "clinical_study": {
        "@rank": "80562", 
        "acronym": "CHESS", 
        "arm_group": [
            {
                "arm_group_label": "Methylphenidate", 
                "arm_group_type": "Experimental", 
                "description": "Methylphenidate"
            }, 
            {
                "arm_group_label": "modafinil", 
                "arm_group_type": "Experimental", 
                "description": "modafinil"
            }, 
            {
                "arm_group_label": "caffeine", 
                "arm_group_type": "Experimental", 
                "description": "caffeine"
            }, 
            {
                "arm_group_label": "placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "placebo"
            }
        ], 
        "brief_summary": {
            "textblock": "Effects of caffeine, methylphenidate, modafinil and placebo on cognitive performance of\n      chess players in chess games and neuropsychiatric standardized tests. We hypothesize that\n      substances will change cognitive performance in chess players leading to changed results in\n      chess games and neuropsychiatric tests."
        }, 
        "brief_title": "Cognitive Hyper-performance - Effects of Stimulating Substances in Chess-players", 
        "completion_date": {
            "#text": "April 2013", 
            "@type": "Actual"
        }, 
        "condition": "Cognitively Healthy Subjects Influenced by Psychoactive Drugs", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  male\n\n          -  18-60 years old\n\n          -  existence of ELO-number\n\n        Exclusion Criteria:\n\n          -  physical diseases (e.g. diabetes mellitus, etc.) with necessity of using prescription\n             drugs\n\n          -  psychiatric diseases (e.g. psychosis, bipolar disorders, etc.) with necessity of\n             using prescription drugs\n\n          -  addiction of psychoactive substances\n\n          -  smoker or quitter (< 5 years)\n\n          -  use of more than 5 cups of coffee per day\n\n          -  irregular day-night-rhythm (e.g. shift workers)"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "60 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "May 25, 2011", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01834547", 
            "org_study_id": "1234"
        }, 
        "intervention": [
            {
                "arm_group_label": "Methylphenidate", 
                "description": "40 mg tablets", 
                "intervention_name": "Drugs use: methylphenidate", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "modafinil", 
                "description": "40 mg tablets", 
                "intervention_name": "Drug use: modafinil", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "caffeine", 
                "description": "400 mg", 
                "intervention_name": "caffeine", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "placebo", 
                "description": "placebo", 
                "intervention_name": "placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Caffeine", 
                "Methylphenidate", 
                "Modafinil"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": "chess, cognition", 
        "lastchanged_date": "April 17, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Mainz", 
                    "country": "Germany", 
                    "zip": "55131"
                }, 
                "name": "Department of Psychiatry and Psychotherapy"
            }
        }, 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_arms": "4", 
        "official_title": "Phase I Study About Effects of Caffeine, Methylphenidate, Modafinil and Placebo on Cognitive Performance of Chess Players.", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Germany: Ethics Commission", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "April 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Chess games (win/ lose/ tie)", 
            "safety_issue": "No", 
            "time_frame": "two years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01834547"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Johannes Gutenberg University Mainz", 
            "investigator_full_name": "K. Lieb", 
            "investigator_title": "Prof. Dr. med. K. Lieb", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "time period for decision of chess games", 
                "safety_issue": "No", 
                "time_frame": "results of ches games"
            }, 
            {
                "measure": "Cognitive performance measured with standardized neuropsychiatric tests (Tower of Hanoi, Trail-Making test, Stroop-Test, Psycho-Motor-Vigilance test, Wisconsin-Card-Sorting-Test, Balloon Analog Risk Task)", 
                "safety_issue": "No", 
                "time_frame": "outcome of tests"
            }, 
            {
                "measure": "measuring of risk taking behaviour, motivation, mood using standardized questionnaires", 
                "safety_issue": "No", 
                "time_frame": "outcome of tests"
            }, 
            {
                "measure": "adverse events", 
                "safety_issue": "Yes", 
                "time_frame": "type of adverse events"
            }
        ], 
        "source": "Johannes Gutenberg University Mainz", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "K. Lieb", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2011", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Health Services Research", 
        "study_type": "Interventional", 
        "verification_date": "April 2013"
    }
}